Sunday, October 02, 2022 1:05:46 PM
Consider companies such as Merck, Pfizer, and Bristol Meyers Squibb. They develop medical products involving scientists and doctors. There is also a business and finance side that funds research, development, manufacturing, and acquisitions. Some people work on the science while others are experts on the business side.
Billionaire Robert Hefner is also on the business side of the DCVax platform technology as an investor. He is billionaire expert on other technologies of global value. Hefner is old and has been researchable for many years. He is business expert whom we can vet. We can scrutinize his judgment and his global work over many decades. We can verify his net worth and professional resume to decide whether his opinion about the DCVax platform technology is a significant and valuable opinion.
Everyone should do their own thorough research of trustworthy sources and not accept anonymous disinformation as true. An independent medical peer review is forthcoming. There are also published sources available now such as those pasted below and many others which anyone can find and evaluate for themselves.
https://soc-neuro-onc.org/
https://www.uclahealth.org/providers/linda-liau
https://connect.uclahealth.org/2022/09/14/brain-cancer-discovery-clinical-trials/
https://www.kcl.ac.uk/people/keyoumars-ashkan
https://www.liverpool.ac.uk/systems-molecular-and-integrative-biology/staff/michael-jenkinson/
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
https://virtualtrials.org/dcvax.cfm
https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext
Billionaire Robert Hefner is also on the business side of the DCVax platform technology as an investor. He is billionaire expert on other technologies of global value. Hefner is old and has been researchable for many years. He is business expert whom we can vet. We can scrutinize his judgment and his global work over many decades. We can verify his net worth and professional resume to decide whether his opinion about the DCVax platform technology is a significant and valuable opinion.
Everyone should do their own thorough research of trustworthy sources and not accept anonymous disinformation as true. An independent medical peer review is forthcoming. There are also published sources available now such as those pasted below and many others which anyone can find and evaluate for themselves.
https://soc-neuro-onc.org/
https://www.uclahealth.org/providers/linda-liau
https://connect.uclahealth.org/2022/09/14/brain-cancer-discovery-clinical-trials/
https://www.kcl.ac.uk/people/keyoumars-ashkan
https://www.liverpool.ac.uk/systems-molecular-and-integrative-biology/staff/michael-jenkinson/
https://www.fda.gov/science-research/advancing-regulatory-science/fda-nih-joint-leadership-council-charter
https://connect.uclahealth.org/2021/03/22/ucla-received-590-million-in-nih-funding-second-highest-total-for-academic-medical-centers-in-2020/
https://virtualtrials.org/dcvax.cfm
https://www.annalsofoncology.org/article/S0923-7534(22)00006-0/fulltext
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
